acivicin and EHS Tumor

acivicin has been researched along with EHS Tumor in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19905 (62.50)18.7374
1990's3 (37.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aoki, T; Burt, ME; Denton, JE; Faderan, MA; Lui, MS; Prajda, N; Reardon, MA; Sebolt, J; Weber, G; Zhen, YS1
Alonso, MT; Leyland-Jones, B; O'Dwyer, PJ1
Anderson, M; Burt, ME; Harrison, LE; Hochwald, SN; Rose, DM1
Cao, L; Chance, WT; Fischer, JE; Zhang, FS1
Cao, LQ; Chance, WT; Fischer, JE1
Cao, L; Chance, WT; Fischer, JE; Foley-Nelson, T; Nelson, JL1
Cao, L; Chance, WT; Fischer, JE1
Cao, L; Chance, WT; Fischer, JE; Kim, MW; Nelson, JL1

Other Studies

8 other study(ies) available for acivicin and EHS Tumor

ArticleYear
Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Advances in enzyme regulation, 1982, Volume: 20

    Topics: Animals; Antimetabolites, Antineoplastic; Cells, Cultured; Dactinomycin; Deoxyribonucleotides; Glutamine; Humans; Isoxazoles; Liver Neoplasms, Experimental; Oxazoles; Rats; Rats, Inbred Strains; Ribonucleotides; Sarcoma, Experimental

1982
Acivicin: a new glutamine antagonist in clinical trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites; Dose-Response Relationship, Drug; Drug Evaluation; Female; Glutamine; Half-Life; Humans; Isoxazoles; Kinetics; Leukemia, Experimental; Liver Neoplasms, Experimental; Macaca mulatta; Male; Mice; Neoplasms; Oxazoles; Purines; Pyrimidines; Sarcoma, Experimental

1984
gamma-Glutamyl transpeptidase mediation of tumor glutathione utilization in vivo.
    Journal of the National Cancer Institute, 1996, Feb-21, Volume: 88, Issue:3-4

    Topics: Animals; Cysteine; Enzyme Inhibitors; Female; gamma-Glutamyltransferase; Glutathione; Isoxazoles; Methylcholanthrene; Rats; Rats, Inbred F344; Sarcoma, Experimental

1996
Clenbuterol plus acivicin decrease tumor growth and increase muscle mass in rats maintained on total parenteral nutrition.
    American journal of surgery, 1991, Volume: 161, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Clenbuterol; Drug Therapy, Combination; Intestine, Small; Isoxazoles; Lipid Metabolism; Liver; Male; Methylcholanthrene; Muscle Proteins; Muscles; Myocardium; Organ Size; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental

1991
Prolonged survival by tumor-bearing rats treated with acivicin and total parenteral nutrition.
    Journal of the National Cancer Institute, 1990, Mar-07, Volume: 82, Issue:5

    Topics: Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; Isoxazoles; Male; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental; Survival Rate

1990
Acivicin reduces tumor growth during total parenteral nutrition (TPN).
    Surgery, 1987, Volume: 102, Issue:2

    Topics: Animals; Antimetabolites; Body Weight; Glutamine; Isoxazoles; Male; Neoplasm Transplantation; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental; Soft Tissue Neoplasms

1987
Insulin and acivicin improve host nutrition and prevent tumor growth during total parenteral nutrition.
    Annals of surgery, 1988, Volume: 208, Issue:4

    Topics: Animals; Antimetabolites; Body Weight; Eating; Energy Intake; Insulin; Isoxazoles; Male; Muscle Proteins; Muscles; Organ Size; Oxazoles; Parenteral Nutrition, Total; Rats; Rats, Inbred F344; Sarcoma, Experimental

1988
Reduction of tumor growth following treatment with a glutamine antimetabolite.
    Life sciences, 1988, Volume: 42, Issue:1

    Topics: Amino Acids; Animals; Antibiotics, Antineoplastic; Antimetabolites; Body Weight; Energy Intake; Glutamine; Isoxazoles; Male; Methylcholanthrene; Oxazoles; Rats; Rats, Inbred F344; Sarcoma, Experimental

1988